Fig. 1: GINA treatment recommendations for patients aged ≥12 years, 6–11 years and ≤5 years3. | npj Primary Care Respiratory Medicine

Fig. 1: GINA treatment recommendations for patients aged ≥12 years, 6–11 years and ≤5 years3.

From: Asthma exacerbations and worsenings in patients aged 1–75 years with add-on tiotropium treatment

Fig. 1

GINA treatment recommendations for stepping up or stepping down of asthma controller and reliever therapy for the management of asthma for patients aged (a) ≥12 years, (b) 6–11 years and (c) ≤5 years. © 2020, Global Initiative for Asthma, reproduced with permission. FEV1 forced expiratory volume in 1s, GINA Global Initiative for Asthma, HDM house dust mite, ICS inhaled corticosteroid, Ig immunoglobulin, IL interleukin, LABA long-acting β2-agonist, LTRA leukotriene receptor antagonist, OCS oral corticosteroids, SABA short-acting β2-agonist, SLIT sublingual immunotherapy.

Back to article page